XILFYA Trademark

Trademark Overview


On Friday, November 15, 2019, a trademark application was filed for XILFYA with the United States Patent and Trademark Office. The USPTO has given the XILFYA trademark a serial number of 88693852. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 30, 2022. This trademark is owned by Pfizer Inc.. The XILFYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
xilfya

General Information


Serial Number88693852
Word MarkXILFYA
Filing DateFriday, November 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 30, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, May 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 30, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 28, 2021SOU EXTENSION 3 GRANTED
Tuesday, September 28, 2021SOU EXTENSION 3 FILED
Tuesday, September 28, 2021TEAS EXTENSION RECEIVED
Friday, March 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 17, 2021SOU EXTENSION 2 GRANTED
Wednesday, March 17, 2021SOU EXTENSION 2 FILED
Wednesday, March 17, 2021TEAS EXTENSION RECEIVED
Thursday, October 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 29, 2020SOU EXTENSION 1 FILED
Tuesday, September 29, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2020ASSIGNED TO EXAMINER
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 19, 2019NEW APPLICATION ENTERED IN TRAM